EQS-Adhoc: LifeWatch AG: LOI with GE Healthcare to develop strategic relationship signed
EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Letter of Intent
LifeWatch AG: LOI with GE Healthcare to develop strategic relationship signed
24.10.2016 / 07:00
Release of an ad hoc announcement pursuant to Art. 53 KR.
--------------------------------------------------------------------------------
LifeWatch signs LOI with GE Healthcare to develop strategic relationship
Zug/Switzerland, October 24, 2016 - LifeWatch AG (SIX Swiss Exchange: LIFE), a
leading developer and provider of medical solutions and remote diagnostic
monitoring services in the digital health market, announces that the company has
signed a Letter of Intent (LOI) with GE Medical Systems Information
Technologies, Inc., a Wisconsin corporation doing business as GE Healthcare,
along with its affiliates (GE Healthcare).
The purpose of the LOI is to explore the opportunities of a long-term strategic
relationship regarding the exclusive third-party distribution of LifeWatch's
monitoring services in the USA and possible other markets as well as other
potential ventures. This LOI is non-binding and the intended relationship is
subject to the signing of a definitive cooperation agreement.
For further questions:
LifeWatch AG, Andrew Moore, CFO
c/o Dynamics Group, Doris Rudischhauser
Phone +41 43 268 27 40 / Mobile +41 79 410 81 88
E-Mail: investor-relations@lifewatch.com
About LifeWatch AG
LifeWatch AG, headquartered in Zug and listed on SIX Swiss Exchange (LIFE),
Switzerland, is a leading healthcare technology and solution company,
specializing in advanced digital health systems and wireless remote diagnostic
patient monitoring services. LifeWatch's services provide physicians with
critical information to determine appropriate treatment and thereby improve
patient outcomes. LifeWatch AG has operative subsidiaries in the United States,
in Switzerland and in Israel, and is the parent company of LifeWatch Services
Inc., and LifeWatch Technologies, Ltd. LifeWatch Services, Inc. is a leading
U.S.-based provider of cardiac monitoring services. LifeWatch Technologies Ltd.,
based in Israel, is a leading developer and manufacturer of telemedicine
products. For additional information, please visit www.lifewatch.com.
Sign up for customized e-mail alerts and documentation requests at
http://www.irlifewatch.com/websites/lifewatch_ir/English/9510/alert-service.html
This press release includes forward-looking statements. All statements other
than statements of historical facts contained in this press release, including
statements regarding future results of operations and financial position, the
business strategy, and plans and objectives for future operations, are
forward-looking statements. The words "believe," "may," "will," "estimate,"
"continue," "anticipate," "intend," "expect" and similar expressions are
intended to identify forward-looking statements. LifeWatch AG has based these
forward-looking statements largely on current expectations and projections about
future events and financial trends that it believes may affect the financial
condition, results of operations, business strategy, short-term and long-term
business operations and objectives, and financial needs. These forward-looking
statements are subject to a number of risks, uncertainties and assumptions. In
light of these risks, uncertainties and assumptions, the forward-looking events
and circumstances described may not occur and actual results could differ
materially and adversely from those anticipated or implied in the
forward-looking statements. All forward-looking statements are based only on
data available to LifeWatch AG at the time of the issue of this press release.
LifeWatch AG does not undertake any obligation to update any forward-looking
statements contained in this press release as a result of new information,
future events or otherwise.
THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF AMERICA AND MUST
NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR PUBLICATIONS WITH A GENERAL
CIRCULATION IN THE UNITED STATES. THIS PRESS RELEASE DOES NOT CONSTITUTE AN
OFFER OF SECURITIES OF LIFEWATCH AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE
UNITED STATES, OR AN INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES OF
LIFEWATCH AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE
SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN REGISTERED UNDER
THE UNITED STATES SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR DELIVERED
WITHIN THE UNITED STATES OR TO U.S. PERSONS ABSENT FROM REGISTRATION UNDER OR AN
APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE UNITED STATES
SECURITIES LAWS.
Additional features:
Document:http://n.eqs.com/c/fncls.ssp?u=VCJULDUWEP
Document title: LifeWatch signs LOI with GE Healthcare to develop strategic
relationship
--------------------------------------------------------------------------------
End of ad hoc announcement------------------------------------------------------
Language: English
Company: LifeWatch AG
Baarerstrasse 139
6300 Zug
Switzerland
Phone: +41 41 728 67 78
Internet: www.lifewatch.com
ISIN: CH0012815459
Valor: 811189
Listed: Regulated Unofficial Market in Berlin, Stuttgart; Open Market in
Frankfurt ; SIX Swiss Exchange
End of News EQS Group News Service
--------------------------------------------------------------------------------
513725 24.10.2016
EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Change of Personnel LifeWatch AG: Dr. Christoph Heinzen nominated Chief Operations & Technology Officer 14.09.2016 / 07:00 Release of an ad hoc announcement pursuant to Art. 53 KR. 501453 14.09.2016 ...
EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Miscellaneous LifeWatch AG: Information about shareholdings by AEVIS VICTORIA SA 24.08.2016 / 18:00 Release of an ad hoc announcement pursuant to Art. 53 KR. 495603 24.08.2016 ...
EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Half Year Results LifeWatch AG: First half-year 2016 financial results 18.08.2016 / 07:00 Release of an ad hoc announcement pursuant to Art. 53 KR. 493727 18.08.2016 ...